MEI Pharma: Massive upside not reflected in today's price $MEIP
www.yetanothervalueblog.com
A failed Phase II trial for their main drug caused investors to abandon MEI Pharma (MEIP) Today, the company trades for below net cash Despite the failed trial, some recent good news suggest there could be significant upside potential hiding here
MEI Pharma: Massive upside not reflected in today's price $MEIP
MEI Pharma: Massive upside not reflected in…
MEI Pharma: Massive upside not reflected in today's price $MEIP
A failed Phase II trial for their main drug caused investors to abandon MEI Pharma (MEIP) Today, the company trades for below net cash Despite the failed trial, some recent good news suggest there could be significant upside potential hiding here